RACK1 acts as a key post‐translational regulator of STAT3, promoting effective Tfh differentiation and humoral immunity during non‐lethal P. yoelii infection. Targeting RACK1–STAT3 axis may enhance vaccine‐induced or natural immunity to malaria. This evidence concerns the gene STAT3 and malaria.